Navigation Links
Progress toward artificial photosynthesis?

Plants can do it: they simply grab carbon dioxide out of the air and covert it into biomass. In this process, known as photosynthesis, the plants use light as their energy source. Chemists would also like to be able to use CO2 as a carbon source for their synthetic reactions, but it doesn’t work just like that. A team headed by Markus Antonietti at the Max Planck Institute for Colloids and Interfaces has now taken an important step toward this goal. As described in the journal Angewandte Chemie, they have successfully activated CO 2 for use in a chemical reaction by using a special new type of metal-free catalyst: graphitic carbon nitride.

"Chemical activation of carbon dioxide, meaning its cleavage in a chemical reaction," explain chemists Goettmann, Thomas and Antonietti, " is one of the biggest challenges in synthetic chemistry." The bonds in this molecule are very stable, so a lot of energy is needed to split them. To date, only a few special metal catalysts are known to be capable of breaking the C–O bonds in CO2.

In contrast to most previous approaches, Antonietti’s team worked with metal-free catalysts, turning toward plants for inspiration. Photosynthesis in modern green plants involves an important intermediate step: the bonding of CO2 to nitrogen atoms to form carbamates. The German researchers thus also experimented with nitrogen-rich catalysts with structures that allow them to form carbamates. Their new class of catalysts is made of flat, graphite-like layers. The individual layers consist of ring systems involving carbon and nitrogen atoms. This porous material, called graphitic carbon nitride, is very heat-stable and, although it enters into many chemical interactions, it is so stable that it nearly always re-forms—an ideal catalyst. It can even be used to activate carbon dioxide. It was thus possible to oxidize benzene (an aromatic six-membered carbon ring) to phenol (which has an additional OH group). The by-product of the reactio
'"/>

Source:John Wiley & Sons, Inc.


Page: 1 2

Related biology news :

1. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
2. AIDS Public Awareness Campaign Expands Following Report Of Rapidly Progressive HIV
3. Progress on HIV/AIDS significant but insufficient
4. Progress being made in exploring potential use of stem cells to treat heart disease
5. Progress made in HIV vaccine development
6. Unchecked DNA replication drives earliest steps toward cancer
7. Virologists make major step towards understanding the process of HIV infection
8. Moffitt-USF head toward first human trials of anti-cancer drug that targets protein AKT
9. Cats indifference towards sugar explained
10. A step toward the $1,000 personal genome using readily available lab equipment
11. A new step towards an AIDS vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Progress toward artificial photosynthesis

(Date:12/17/2014)... Dec. 15, 2014 The Defense Logistics ... easier to detect and prevent counterfeit microcircuits from ... the agency started performing an in-house microcircuit anti-counterfeit ... the authenticity of purchased microcircuits while increasing their ... control measures will be conducted at DLA,s Electronics ...
(Date:12/15/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used ... measures the overall facial feature of a person ... distance between eyes. Facial recognition is used for ...
(Date:12/10/2014)... NEW YORK , Dec. 8, 2014 You,ve ... online banking account but can,t remember your password, site key ... birthday? Who was your first grade teacher? ... launches the app that will finally put an ... PINs – 1U TM . 1U leverages a ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... trial led by a researcher at the University of ... a new approach to treat triple-negative breast cancer, an ... African-Americans and young women. The study will help researchers ... cells to express a protein called an estrogen receptor ...
... lead the first international, multidisciplinary assessment of the levels ... off the Fukushima nuclear power planta research effort funded ... "This project will address fundamental questions about the ... and in the process enhance international collaboration and sharing ...
... PHILADELPHIA (June 2, 2011) -- Although bitterness can sometimes ... or chocolate more often bitter taste causes rejection that ... is especially true for children. Now, scientists from the Monell ... that inhibits bitterness by acting directly on a subset of ...
Cached Biology News:New clinical trial to test novel approach to treat triple-negative breast cancer 2New clinical trial to test novel approach to treat triple-negative breast cancer 3Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 2Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 3Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 4Woods Hole Oceanographic Institution leads expedition to measure radioactive contaminants in Pacific 5New bitter blocker discovered 2
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
(Date:12/22/2014)... VANCOUVER , Dec. 22, 2014 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development of ... paper out of the University of Calgary in conjunction ... North Carolina, which further validates the company,s ongoing clinical ... the effects of pattern baldness. The paper ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
(Date:12/19/2014)... Lawrence, MA (PRWEB) December 19, 2014 ... flow MRLAFMQ test for the Detection of Aflatoxin M1 ... test to receive independent third party validation. The peer ... Science Unit of the Institute for Agricultural and Fisheries ... Francis Group. , Aflatoxin B1, the most toxic ...
Breaking Biology Technology:Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... , , Multiporator / Electroporator 2510 , , , , , , ... Transformation Protocol , Protocol No. 4308 915.519 12/2001 , , ... , , , Microorganism , ... Cell type , Bacteria, gram positive, ...
... / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.516 12/2001 , , , , ... , Microorganism , Kluyveromyces lactis ... type , Yeast, , , ...
... , , , , , , Multiporator / Electroporator 2510 , , ... , Transformation Protocol , Protocol No. 4308 915.509 ... , , , , , , ... , Cell type , ...
Cached Biology Technology:Lactococcus lactis 2Kluyveromyces lactis 2Clostridium botulinum 2
Polymerase (RNA) II (DNA directed) polypeptide L...
Chicken Anti-Human DNA-directed RNA Polymerase II 7.6 Kd Polypeptide (POLR2L Polyclonal AntibodyOther Sub-Family: not assigned-Other Applications: ELISA, Western Blot...
The BD CBA Human Apoptosis Kit can be used to quantitatively measure,cleaved PARP, Bcl-2, and active Caspase-3 protein levels in a single sample. The,Kit performance has been optimized for analysis o...
... of ICE-family proteases/caspases initiates apoptosis in mammalian ... Detection Kit provides a simple and convenient ... flow cytometry in intact cells. The ... aspartate residues linked to rhodamine 110 (D2R), ...
Biology Products: